Quant Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 1.22 %Nav, as on 23-01-2025

  • Previous Nav

  • Net Change on 23-01-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty India Consumption - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 21.35 19.23 25.77 1.80 8,914.89
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 34.34 23.90 28.58 1.91 5,320.29
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 29.60 22.95 27.55 1.94 3,628.03
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 31.20 21.89 27.95 1.90 3,339.79
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 26.95 17.64 26.57 1.92 2,863.52

Fund Holdings as on 31-December-2024

  • Aster DM Healthcare Limited

  • RPG Life Sciences Limited

  • Pfizer Ltd

  • Aurobindo Pharma Limited

  • IPCA Laboratories Ltd

  • Zydus Lifesciences Limited

  • HFCL Limited

  • Reliance Industries Limited

  • Zydus Wellness Ltd

  • Glenmark Life Sciences Limited

  • Sequent Scientific Limited

  • Glaxosmithkline Pharmaceuticals Ltd

  • Aarti Pharmalabs Limited

  • SMS Pharmaceuticals Limited

  • Suraksha Diagnostic Limited

  • Suven Life Sciences Ltd.

  • Torrent Pharmaceuticals Ltd

  • 91 Days Treasury Bill 21-Feb-2025

  • Alembic Pharmaceuticals Limited

  • Sanofi Consumer Healthcare India Limited

  • Ami Organics Limited

  • Thyrocare Technologies Limited

  • TREPS 01-Jan-2025 DEPO 10

  • Dr. Reddy's Laboratories Limited 30/01/2025

  • NCA-NET CURRENT ASSETS

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Telecom-Infrastructure

  • Refineries

  • Consumer Food

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Derivatives

  • Equity

  • SOV

View More

About Quant Healthcare Fund

Scheme Analysis

Quant Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Quant Mutual Fund. It was launched on 17-Jul-2023 and currently has an AUM of ₹424.04 crore. Quant Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty India Consumption - TRI as secondary index.

The NAV of Quant Healthcare Fund ended up ₹0.18(1.22%)yesterday to ₹15.2284.

Among its top 3 holdings the fund has exposure to Aster DM Healthcare Limited, and

The Quant Healthcare Fund is managed by Sanjeev Sharma and Vasav Sahgal.

Fund House Contact

6th Floor, Sea Breeze Building, Appa Saheb Marathe Marg, Prabhadevi, Mumbai - 400025

022-6295 5000
help@quant.in
022-6295 5000